can you go on and off semaglutide Discontinuation Its Health Implications Semaglutide, also known as Ozempic,

Forbes and USA Today logos are displayed prominently with zero links for sourcing

Eur J Pharm Biopharm 152:95107 Uygur MM, Villanova M, Frara S, Giustina A (2024) Clinical pharmacology of oral octreotide capsules for the treatment of acromegaly

Common causes of lymphadenopathy that may coincidentally occur during GLP-1 treatment include: Viral or bacterial infections : Upper respiratory tract infections, pharyngitis, dental infections, and other common illnesses frequently cause reactive lymph node enlargement, particularly in the neck, jaw, or armpit regions Localised skin infections or inflammation : Cellulitis, abscesses, or infected wounds near lymph node chains can trigger regional lymphadenopathy Systemic infections : Conditions such as infectious mononucleosis (glandular fever), cytomegalovirus, or toxoplasmosis may present with generalised lymph node swelling Immune-mediated conditions : Rheumatoid arthritis, lupus, and other autoimmune disorders can cause lymphadenopathy Malignancy : Lymphomas, leukaemias, or metastatic cancer may present with persistent or progressive lymph node enlargement Recent vaccination : Transient lymph node enlargement in the region draining the vaccination site is a common benign reaction It is worth noting that injection site reactions are recognised side effects of GLP-1 medications, typically manifesting as localised redness, swelling, or discomfort at the injection site rather than distant lymph node enlargement

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Mild injection-site reactions Transient hunger (mild) Rare water retention Rare mild flushing Known interactions Concurrent rhGH not recommended Insulin / glucose-lowering agents (mild hyperglycemia possible) Contraindications Active malignancy Pituitary tumor Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved